Industries > Pharma > Gastrointestinal Devices: World Market 2013-2023

Gastrointestinal Devices: World Market 2013-2023

PUBLISHED: 06 March 2013
PAGES: 189
PRODUCT CODE:

Clear
WOOCS 2.2.1

Your guide to trends and revenue prospects for gastrointestinal devices

What does the future hold for treating gastrointestinal disorders? Visiongain's new report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for gastrointestinal devices. There's rising demand for those products.

Our study lets you assess sales data at overall world market, submarket and national level. There you find that industry's most promising and lucrative segments, helping your research and analyses.

Forecasts and other analyses to help you stay ahead in knowledge

In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT and Porter's five force analysis), business news, outlooks and developmental trends. Also, you receive 72 tables and 100 charts.

You discover industry dynamics and growth potentials – the following sections show what you find in our new report.

Discover prospects for the world market and submarkets

Along with revenue prediction for the overall world market, you see forecasts to 2023 for these four submarkets:
• Gastrointestinal endoscopy devices
• Bariatric surgery devices
• Ostomy devices
• Enteral feeding pumps.

With our investigation you gain business research and analysis with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints. See what's likely to achieve the most success.

You can gain competitive advantages by understanding the trends, opportunities and challenges facing the gastrointestinal devices market.

Our work also breaks the main world forecast into leading geographical markets.

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There exist many opportunities for medical device companies developing technologies for treating gastrointestinal disorders. See prospects for the industry.

You get individual forecasts to 2023 for nine national markets, finding overall revenues:
• US
• Japan
• Germany, France, UK, Italy and Spain
• India and China.

Discover progress and outlooks. You assess the industry's future – hear about developments and find their significance. Our work explains, exploring many issues.

What affects medical device treatments for gastrointestinal disorders?

Our report discusses issues and events affecting that industry and market from 2013, looking ahead:
• Shifting dynamics in the GI market
• Escalating levels of worldwide obesity
• Minimally invasive technologies
• Reimbursement outlook in key segments of the market
• Strengths and weaknesses of the gastrointestinal devices market

Also, you find coverage of these aspects:
• Medical device excise tax
• Competition from pharmaceuticals
• Regulatory harmonisation across major international markets
• Expanding healthcare coverage in emerging markets.

See what the future holds. You investigate technological, commercial, economic and political matters, with emphasis on the competitive landscape and business outlooks.

Leading companies and 2015 market value

What will happen next? We predict the overall world market for gastrointestinal devices will reach $18.2bn in 2015, and expand further to 2023.

Our study shows you what technologies, products and organisations hold greatest potential. We explore these leading companies:
• Ethicon-Endo Surgery (J&J)
• Olympus
• Boston Scientific
• Coloplast
• Given Imaging
• CONMED
• Covidien

From 2013 to 2023, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.

Seven ways Gastrointestinal Devices: World Market 2013-2023 helps

To sum up, our investigation gives you the following knowledge:
• Revenues to 2023 for the overall world market and 4 submarkets – you discover that industry's prospects
• Forecasting to 2023 for US, Japan, Germany, France, UK, Spain, Italy, India and China – you see leading national sales potentials
• Assessments of 7 leading companies – you find activities, products, capabilities and outlooks
• Understanding of competition and opportunities – you see what affects that industry, learning what shapes its future
• Analysis of what stimulates and restrains the industry and market – you assess challenges and strengths,
• Analysis of microenvironment – helping you compete and gain advantages
• Prospects for established firms and those seeking to enter the sector – you explore needs, practices and outlooks for success.

Benefit from our analyses, gaining information found nowhere else

That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.

With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.

Discover technological and commercial prospects from 2013 by ordering now

Visiongain's study is for everyone needing analysis of the industry and market for gastrointestinal devices. You find data, trends and predictions. Please ask for our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Gastrointestinal Devices: World Market 2013-2023


Download sample pages

Complete the form below to download your free sample pages for Gastrointestinal Devices: World Market 2013-2023


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories